Related Experiment Videos

[Mechanisms of the phenazepam oxidation reactions in cell membranes]

Farmakologiia I Toksikologiia
|May 1, 1984
PubMed

Insights

Phenazepam oxidation in animal liver microsomes primarily requires nicotinamide adenine dinucleotide phosphate (NADP-H) as an electron donor. This enzymatic process is inhibited by SKF-525A, indicating a role for cytochrome P450 enzymes.

Area of Science:

  • Pharmacology and Toxicology
  • Biochemistry and Metabolism

Background:

  • Phenazepam is a benzodiazepine derivative with known pharmacological effects.
  • Liver microsomes are crucial for the metabolism of xenobiotics, including drugs.
  • Understanding drug metabolism pathways is essential for predicting drug efficacy and toxicity.

Purpose of the Study:

  • To investigate the enzymatic oxidation pathways of phenazepam in vitro.
  • To identify the key cofactors and enzymes involved in phenazepam metabolism.
  • To elucidate the mechanisms of phenazepam biotransformation in different animal models.

Main Methods:

  • Incubation of phenazepam with liver microsomes from rats, mice, and rabbits.
  • Use of nicotinamide adenine dinucleotide phosphate (NADP-H) and nicotinamide adenine dinucleotide (NAD-H) as electron donors.
  • Inhibition studies using SKF-525A, a known monooxygenase inhibitor.

Main Results:

  • Maximal phenazepam oxidation occurred when NADP-H was the electron donor.
  • NAD-H did not significantly enhance phenazepam oxidation.
  • SKF-525A inhibited phenazepam oxidation, with varying effects across different animal species.

Conclusions:

  • Phenazepam oxidation in rat, mouse, and rabbit liver microsomes is dependent on NADP-H-supported enzymatic systems, likely involving cytochrome P450 enzymes.
  • The study discusses the enzymatic formation of phenazepam's 3-hydroxymetabolite, quinazoline, and aromatic hydroxylation products.
  • Species-specific differences in phenazepam metabolism may exist, influenced by monooxygenase activity.

Related Concept Videos